In the article on how crocetin inhibits pancreatic cancer growth in the February 2009 issue (1), there was an error in the affiliations section. The correct affiliations should have read as follows: Animesh Dhar,1,4 Smita Mehta,1,4 Gopal Dhar,4 Kakali Dhar,4 Snigdha Banerjee,1,4 Peter Van Veldhuizen,1,4 Donald R. Campbell,3,4 and Sushanta K. Banerjee1,2,4. 1Hematology and Oncology and 2Department of Anatomy and Cell Biology, University of Kansas Medical Center, and 3Department of Medicine, Saint Luke’s Hospital and University of Missouri, Kansas City, Kansas; and 4Cancer Research Unit, Kansas City Veterans Affairs Medical Center, Kansas City, Missouri. The address for correspondence should have read the following: Animesh Dhar, PhD, or Donald R. Campbell, MD, Cancer Research Unit, Research Division 151, VA Medical Center, 4801 Linwood Boulevard, Kansas City, MO, 64128. Phone: 816-861-4700, ext. 57103; Fax: 816-922-3320. E-mail: adhar@kumc.edu or dcampbell@saint-lukes.org. Also, NIH COBRE award 1 P20 RR15563 (S. Banerjee) should have appeared in the grant support.

1
Dhar A, Mehta S, Dhar G, Dhar K, Banerjee S, Van Veldhuizen P, Campbell DR, Banerjee SK. Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model.
Mol Cancer Ther
2009
;
8
:
315
–23.